Table 1.
Clinical Characteristics of Respiratory Syncytial Virus–Positive and –Negative Patients
| Characteristic | Positive (n=7) | Negative (n=15) |
|---|---|---|
| Age, mean ± SD | 68.1 ± 16.8 | 72.0 ± 14.5 |
| Female, n (%) | 1 (14.3) | 1 (6.7) |
| African American, n (%) | 4 (57.1) | 7 (46.7) |
| Charleson comorbidity score | 6.57 ± 1.13 | 7.64 ± 2.82 |
| Smoking (current or past), n (%) | 7 (100) | 12 (80.0) |
| Previous vaccination, n (%) | ||
| Influenza vaccine | 6 (85.7) | 15 (100) |
| Pneumococcal vaccine | 6 (85.7) | 13 (86.7) |
| Death at 60 days, n (%) | 1 (14.3) | 0 |
| Immunosuppression, current or past 30 days | 0 | 2 (13.3) |
| Radiation therapy above diaphragm, current or previous 30 days | 0 | 1 (6.7) |
| Bed or wheelchair bound | 4 (57.1) | 8 (53.3) |
| Symptoms, n (%) | ||
| Wheezing | 3 (42.9) | 4 (26.7) |
| Rhinorrhea | 4 (57.1) | 6 (40.0) |
| Sore throat | 2 (28.6) | 3 (20.0) |
| Change in sputum production | 5 (71.4) | 7 (46.7) |
| New or increased cough | 5 (71.4) | 9 (60.0) |
| Myalgia | 3 (42.9) | 2 (13.3) |
| Hoarseness | 2 (28.6) | 2 (13.3) |
| Sneezing | 1 (14.3) | 5 (33.3) |
| Pleuritic chest pain | 2 (28.6) | 1 (6.7) |
| Shortness of breath | 2 (28.6) | 4 (26.7) |
| Subjective limitation of routine activities * | 4 (57.1) | 2 (13.3) |
*
P=.05.
SD=standard deviation.